Federica Agosta1, Silvia Basaia1, Elisa Canu1, Francesca Imperiale1, Giuseppe Magnani2, Monica Falautano2, Giancarlo Comi2, Andrea Falini3, and Massimo Filippi1,2
1Neuroimaging Research Unit, INSPE, Division of Neuroscience, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy, 2Department of Neurology, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy, 3Department of Neuroradiology, San Raffaele Scientific Institute, Vita-Salute San Raffaele University, Milan, Italy
Synopsis
We investigated structural and functional brain
network architecture in patients with Alzheimer’s disease (AD) and mild
cognitive impairment (MCI); and assessed the relationship between healthy brain
network functional connectivity and the topography of brain atrophy in patients
along the AD continuum. Structural connectivity alterations distinguished MCI
who converted to AD from those who did not. Brain regions most strongly
connected with the disease-epicenter (left hippocampus) in the healthy functional
connectome were also the most atrophic in both AD and converters MCI. Graph
theoretical analysis provides insight on how neurodegeneration
propagates across the human brain in the early phase of AD.
Introduction
Abnormal propagation of amyloid β and tau in
Alzheimer’s disease (AD) has been
suggested to be mediated by the extremely complex, yet highly structured
topology of the underlying connectional architecture. The study of the effects
of the disease on the brain networks along the AD continuum is critical in
conceptualizing and predicting this networked disease evolution in vivo. In this study, we investigated structural and functional brain network
architecture in patients with AD and amnestic mild cognitive impairment (aMCI),
stratified in converters (c-aMCI) and non-converters (nc-aMCI) to AD; and assessed
the relationship between healthy brain network functional connectivity and the
topography of brain atrophy in patients along the AD continuum.Methods
Ninety-four
AD patients, 47 aMCI patients (25 c-aMCI within 36 months) and 53 age- and
sex-matched healthy controls were studied. Participants underwent 3D
T1-weighted MRI, diffusion tensor MRI and resting state functional MRI. Graph
analysis and connectomics assessed global and local, structural and functional
topological network properties and regional connectivity. Healthy topological
features of brain regions were assessed based on their connectivity with the
point of maximal atrophy (epicenter) in AD and aMCI patients.Results
Brain
network graph analysis
properties were severely altered in AD patients. Structural brain network was
already altered in c-aMCI patients relative to healthy controls in particular
in the temporal and parietal brain regions, while functional connectivity did
not change. Structural connectivity alterations distinguished c-aMCI from
nc-aMCI cases. In both AD and c-aMCI, the point of maximal atrophy was located
in left hippocampus (epicenter). The brain regions with the strongest functional
connectivity strength and the shortest topological distance with the epicenter
in healthy subjects included the right posterior cingulate cortex and
hippocampus, left orbitofrontal gyrus and bilateral temporal pole, parahippocampi,
amygdala and precuneus. In AD and c-aMCI, regional atrophy correlated
negatively with the regional topological distance with the epicenter in
controls (Figure). Furthermore, a positive correlation was also found between
regional atrophy in patients and the functional connectivity strength with the
epicenter in controls (Figure).Discussion
Progressive
degeneration in the AD continuum is associated with an early breakdown of anatomical brain
connections and follows the strongest connections with the disease-epicenter. These
findings support the hypothesis that the topography of brain connectional
architecture can modulate the spread of AD through the brain.Conclusions
Characterizing the
brain as a network using diffusion tensor and resting state functional MRI and
graph theoretical analysis provides insight on how neurodegeneration propagates
across the human brain in the early phase of AD.Acknowledgements
The study was supported by the Italian Ministry of Health
(grant number GR-2010-2303035) and Alzheimer’s Drug Discovery
Foundation (grant number 20131211).References
No reference found.